Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Nephron Clin Pract. 2010;114(3):c173-7. doi: 10.1159/000262299. Epub 2009 Nov 28.
Randomized controlled trials (RCTs) are considered the gold standard study design to investigate the effect of health interventions, including treatment. However, in some situations, it may be unnecessary, inappropriate, impossible, or inadequate to perform an RCT. In these special situations, well-designed observational studies, including cohort and case-control studies, may provide an alternative to doing nothing in order to obtain estimates of treatment effect. It should be noted that such studies should be performed with caution and correctly. The aims of this review are (1) to explain why RCTs are considered the optimal study design to evaluate treatment effects, (2) to describe the situations in which an RCT is not possible and observational studies are an adequate alternative, and (3) to explain when randomization is not needed and can be approximated in observational studies. Examples from the nephrology literature are used for illustration.
随机对照试验(RCTs)被认为是研究健康干预措施效果的黄金标准研究设计,包括治疗效果。然而,在某些情况下,进行 RCT 可能是不必要的、不适当的、不可能的或不充分的。在这些特殊情况下,精心设计的观察性研究,包括队列研究和病例对照研究,可以提供一种替代方案,以避免在没有治疗效果估计的情况下无所作为。应该注意的是,应该谨慎地正确进行此类研究。本综述的目的是:(1)解释为什么 RCT 被认为是评估治疗效果的最佳研究设计;(2)描述 RCT 不可行而观察性研究是一个充分替代方案的情况;(3)解释何时不需要随机化,并且可以在观察性研究中近似随机化。文中使用肾脏病学文献中的示例进行说明。